InsidersTradesSigma
Track the 인트로메딕 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 인트로메딕 has logged 17 public disclosures. The latest transaction was disclosed on 8 January 2026 (Other). Among the most active insiders: 인트로메딕. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
17 of 17 declarations
인트로메딕 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development of innovative medical technologies.